Keyphrases
Minimal Residual Disease
100%
Acute Myeloid Leukemia
100%
Disease Levels
100%
Copy number
50%
Disease Monitoring
33%
Commercial Standards
33%
Clinical Significance
16%
Quantitative PCR
16%
Clinical Trials
16%
Technical Aspects
16%
Runt-related Transcription Factor 1 (RUNX1)
16%
NPM1 mutation
16%
Nucleophosmin 1 (NPM1)
16%
Clinical Management
16%
Isocitrate Dehydrogenase 1 (IDH1)
16%
Disease Response
16%
Specific mutation
16%
Clinical Decisions
16%
Plasmid-borne
16%
Simple Tools
16%
Reference Gene
16%
Core-binding Factor
16%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
NPM1
100%
Real-Time Polymerase Chain Reaction
50%
Plasmid
50%
RUNX1
50%
Clinical Trial
50%
IDH1
50%
Core Binding Factor
50%
Medicine and Dentistry
Minimal Residual Disease
100%
Acute Myeloid Leukemia
100%
NPM1
33%
Clinical Trial
16%
Real-Time Polymerase Chain Reaction
16%
Plasmid
16%
Clinical Management
16%
Core Binding Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Minimal Residual Disease
100%
Acute Myeloid Leukemia
100%
Clinical Trial
16%
Core Binding Factor
16%